Ranking Alexa Global: # 3,741,218
Server:cloudflare...
X-Powered-By:PHP/5.6.36
The main IP address: 104.28.1.194,Your server Singapore,Singapore ISP:CloudFlare Inc. TLD:uk CountryCode:SG
The description :campaign for access to treatments for spinal muscular atrophy...
This report updates in 27-Jun-2018
Created Date: | 08-Jan-2017 |
Changed Date: | 02-Jan-2018 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host treatsma.uk. Currently, hosted in Singapore and its service provider is CloudFlare Inc. .
Latitude: | 1.2896699905396 |
Longitude: | 103.85006713867 |
Country: | Singapore (SG) |
City: | Singapore |
Region: | Singapore |
ISP: | CloudFlare Inc. |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called cloudflare containing the details of what the browser wants and will accept back from the web server.
Expect-CT: | max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" |
X-Powered-By: | PHP/5.6.36 |
Transfer-Encoding: | chunked |
Set-Cookie: | __cfduid=db42c5bb3a8a1f535fd4ce27e09ce833f1530068701; expires=Thu, 27-Jun-19 03:05:01 GMT; path=/; domain=.treatsma.uk; HttpOnly; Secure |
Expires: | Wed, 04 Jul 2018 03:05:02 GMT |
Vary: | Accept-Encoding,Cookie,User-Agent |
Server: | cloudflare |
Connection: | keep-alive |
Link: | |
X-UA-Compatible: | IE=edge |
Cache-Control: | max-age=604800 |
Date: | Wed, 27 Jun 2018 03:05:04 GMT |
CF-RAY: | 4314b0886b9891ee-EWR |
Content-Type: | text/html; charset=UTF-8 |
Content-Encoding: | gzip |
soa: | bruce.ns.cloudflare.com. dns.cloudflare.com. 2028132798 10000 2400 604800 3600 |
ns: | bruce.ns.cloudflare.com. kami.ns.cloudflare.com. |
ipv4: | IP:104.28.1.194 ASN:13335 OWNER:CLOUDFLARENET - Cloudflare, Inc., US Country:US IP:104.28.0.194 ASN:13335 OWNER:CLOUDFLARENET - Cloudflare, Inc., US Country:US |
ipv6: | 2400:cb00:2048:1::681c:1c2//13335//CLOUDFLARENET - Cloudflare, Inc., US//US 2400:cb00:2048:1::681c:c2//13335//CLOUDFLARENET - Cloudflare, Inc., US//US |
txt: | "zoho-verification=zb15149253.zmverify.zoho.eu" "facebook-domain-verification=49y2q651z42js48uf2qh4k2zvgkfh5" "google-site-verification=U3PsMsDn6BigXx6g6NEAUI4btWgpWkCdJU05RlnxoC8" "v=spf1 ip4:193.107.88.70 include:_spf.google.com include:zoho.eu ~all" |
mx: | MX preference = 10, mail exchanger = alt3.aspmx.l.google.com. MX preference = 1, mail exchanger = aspmx.l.google.com. MX preference = 5, mail exchanger = alt1.aspmx.l.google.com. MX preference = 5, mail exchanger = alt2.aspmx.l.google.com. MX preference = 10, mail exchanger = alt4.aspmx.l.google.com. |
skip to main content campaign for access to treatments for spinal muscular atrophy about the team who we are working with contact us what is sma what is sma? how is sma inherited? how many people have sma? sma types explained standard of care newly diagnosed? treatments treatments spinraza® risdiplam branaplam avxs-101 reldesemtiv olesoxime off-label drugs living with sma our work what we are working on nusinersen eap sma treatment map sma videos media campaigns join the fight donate to help us carry on tell others about sma contact your mp join our team updates campaign for access to treatments for spinal muscular atrophy exciting news about new oral molecule for sma 20/06/2018 on 16th june, ptc therapeutics, inc. presented new interim data from part 1 of the firefish clinical trial which is investigating risdiplam in babies with type 1 sma. the compound is showing some fantastic results, with part 2 of the study still ongoing. this is a very exciting time for sma research. read more → scotland: new approval pathway for ultra-orphan medicines 19/06/2018 people in scotland with rare diseases may be able to access new treatments in a more efficient manner following the introduction of a new definition of ‘ultra-orphan medicines’. ‘ultra-orphan medicines’ will include medicines that can treat people with very rare conditions affecting fewer than 1 in 50,000 people, or approximately 100 individuals in scotland. read more → encouraging results of a new muscle drug for sma 17/06/2018 cytokinetics announced results of a recently completed clinical trial of reldesemtiv in sma. the data suggest that this new experimental drug for sma increases endurance and respiratory function even over a short period of 8 weeks. read more → the sunfish trial will not be conducted in the uk 14/06/2018 yesterday have been made aware that the great ormond street hospital for children will not be taking part in the roche sunfish trial that was to include sma patients with types 2 and 3. this means that the trial will not be conducted in the uk at all. read more → sunfish trial progressing fast but not in the uk 08/06/2018 the sunfish clinical trial is progressing fast, and all of its planned 186 participants will likely be recruited in the next few weeks. as of last week, enrollment of participants aged 6–11 and 18–25 years has been completed globally. however, nobody in the uk in those age groups will participate in this long-awaited trial as the all-too-prevalent red tape has impeded the opening of uk trial sites. read more → registration for nice meeting on spinraza now open to public 04/06/2018 on 27 june 2018, nice appraisal committee will meet in manchester to discuss draft recommendation for spinraza provision in england and wales. parts of the meeting will be open to the public and you are welcome join. read more → roche stops olesoxime development 30/05/2018 today roche announced they decision to stop the development of olesoxime, a neuroprotective drug that showed benefit in spinal muscular atrophy. below is their statement: read more → biogen responds to the open letter 23/05/2018 we have received a reply to the open letter that we sent to biogen after the recent smc recommendation of spinraza. please read below. read more → older posts → search submit is a uk community of people with spinal muscular atrophy (sma) as well as parents of children with sma who have joined hands to fight for wide and equitable access to treatment. we work entirely on a voluntary and non-profit basis, being driven by our committment to saving the lives of ourselves and of our dear ones. is a small charity governed by the laws of england and wales. registered address: 1 alder lodge, warberry park gardens, royal tunbridge wells tn4 8gl. copyright © 2018 . all rights reserved log in back to top × function mp_search() { ?>
https://www.treatsma.uk/sma/
https://www.treatsma.uk/join/contact-your-mp/
https://www.treatsma.uk/treatments/branaplam/
https://www.treatsma.uk/work/map/
https://www.treatsma.uk/treatments/spinraza/
https://www.treatsma.uk/teams/all/
https://www.treatsma.uk/treatments/reldesemtiv/
https://www.treatsma.uk/treatments/
https://www.treatsma.uk/2018/05/biogen-responds-to-the-open-letter/
https://www.treatsma.uk/work/media-campaigns/
https://www.treatsma.uk/donate/?nocache=1
https://www.treatsma.uk/treatments/off-label-treatments/
https://www.treatsma.uk/sma/inheritance/
https://www.treatsma.uk/view/stories/
https://www.treatsma.uk/treatments/avxs-101/
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain name:
treatsma.uk
Data validation:
Nominet was able to match the registrant's name and address against a 3rd party data source on 18-Jul-2016
Registrar:
Fasthosts Internet Ltd [Tag = LIVEDOMAINS]
URL: http://www.fasthosts.co.uk
Relevant dates:
Registered on: 08-Jan-2017
Expiry date: 08-Jan-2019
Last updated: 02-Jan-2018
Registration status:
Registered until expiry date.
Name servers:
bruce.ns.cloudflare.com
kami.ns.cloudflare.com
WHOIS lookup made at 04:05:06 27-Jun-2018
--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2018.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at https://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REFERRER http://www.nominet.org.uk
REGISTRAR Nominet UK
SERVERS
SERVER uk.whois-servers.net
ARGS treatsma.uk
PORT 43
TYPE domain
DOMAIN
SPONSOR
Fasthosts Internet Ltd [Tag = LIVEDOMAINS]
URL: http://www.fasthosts.co.uk
Relevant dates:
CREATED 08-Jan-2017
CHANGED 02-Jan-2018
STATUS
Registered until expiry date.
NSERVER
BRUCE.NS.CLOUDFLARE.COM 173.245.59.77
KAMI.NS.CLOUDFLARE.COM 173.245.58.177
NAME treatsma.uk
DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2018.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at https://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REGISTERED no
The following list shows you to spelling mistakes possible of the internet users for the website searched .